RCS - ThinkSono Ltd - ThinkSono Joins Butterfly Network's AI Marketplace
06/10/2023 14:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231006:nRSF0210Pa&default-theme=true
RNS Number : 0210P ThinkSono Ltd 06 October 2023
ThinkSono Joins Butterfly Garden to Deploy ThinkSono AI on Butterfly's Imaging
Platform
ThinkSono enters Butterfly Garden, leveraging Butterfly Network's software
development kit (SDK) to build and deploy ThinkSono AI that will be compatible
with Butterfly's leading imaging platform.
LONDON, UK / ACCESSWIRE / October 6, 2023 / - ThinkSono Ltd
(https://pr.report/-uscz5Sw) ("ThinkSono") a leading Ultrasound AI company,
today announced it has joined Butterfly Garden (https://pr.report/wfm7zLdq) ,
an artificial intelligence (AI) Marketplace launched by Butterfly Network, Inc
(https://pr.report/pConrFq7) , ("Butterfly") a digital health company
transforming care through the power of portable, semiconductor-based
ultrasound technology and intuitive software.
Under this partnership, ThinkSono plans to build ThinkSono AI training
solutions and ThinkSono Guidance, a deep vein thrombosis (DVT) clinical
solution for use with Butterfly's single-probe, whole-body handheld ultrasound
system, subject to applicable approvals and authorizations. ThinkSono and
Butterfly aim to enable healthcare practitioners to learn several key
point-of-care ultrasound scans, including the detection of deep vein
thrombosis (DVT).
Venous thromboembolism
Venous thromboembolism (VTE) is associated with a major global burden of
disease. Worldwide, the incidence of VTE is 1-3 per 1000 individuals, rising
to 2-7 per 1000 in individuals aged over 70 years, and 3-12 per 1000 in those
over 80 years. VTE, deep vein thrombosis (DVT) and pulmonary embolus (PE) are
the leading cause of hospital-related disability-adjusted life years lost.
Using these estimates, and using the most conservative incidence figure,
globally at least 7.7 million people will require investigation for VTE every
year. An aging population across many countries will lead to a greater health
burden, particularly in middle- and low-income countries where early death
from infection is decreasing.
Mortality from VTE is common, a European study estimated 534,000 deaths per
year and a similar study in the US reported 300,000 deaths per year. DVT has a
high level of morbidity. 30-50% of the surviving patients develop long-term
symptoms in their affected leg (post-thrombotic syndrome).(1)
Opportunity for the Future
In August 2023, Butterfly Network launched (https://pr.report/qGPdwaEY)
Butterfly Garden, allowing third-party developers access to its proprietary
SDK and APIs to build new AI applications that work in conjunction with
Butterfly's imaging platform, bringing with it access to their prominent
point-of-care ultrasound customer base. ThinkSono, with its real-time
ultrasound AI capabilities, was an ideal match for the program.
Fouad Al Noor, CEO and Co-Founder of ThinkSono commented, "We are hugely
excited to deploy ThinkSono's real-time AI software on Butterfly's platform
due to the extensive reach, real-time ultrasound streaming capabilities and
integration with the entire Butterfly ecosystem. Butterfly has the largest
community of handheld POCUS users worldwide, and so it was a natural choice
for us to seek to partner with them."
Darius Shahida, Butterfly Network's Chief Strategy Officer & Chief
Business Development Officer, added, "We are excited to welcome ThinkSono to
the Butterfly Garden. Their innovative AI and technology are great early
examples of the types of tools we hope to bring to our community of users
through Butterfly Garden - a premier destination for AI in ultrasound."
About ThinkSono
Founded in 2016, ThinkSono (www.thinksono.com (https://pr.report/OHpyFRSJ) )
has developed the world's first real-time Ultrasound AI software to enable
non-ultrasound healthcare staff to perform DVT scans. This technology
addresses the worldwide unmet medical need for better DVT detection.
Furthermore, ThinkSono is developing training solutions for other ultrasound
AI applications which aims to increase access to ultrasound imaging and
upskilling non-ultrasound trained healthcare staff to perform key ultrasound
scans. ThinkSono's DVT solution has already been trialed in hospitals across
the UK, EU and is now expanding into the U.S.
With several patents granted and multiple peer-reviewed papers published in
prominent journals such as Nature Digital Medicine, ThinkSono has demonstrated
its leadership in the Ultrasound AI space. The company aims to enable any
healthcare professional to use the power of ultrasound to diagnose disease and
increase the universal access to ultrasound imaging.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011 and listed on the New York Stock
Exchange through a business combination with Longview Acquisition Corp.,
Butterfly created the world's first handheld, single probe whole-body
ultrasound system using semiconductor technology, the Butterfly iQ+.
Butterfly's mission is to democratize medical imaging and contribute to the
aspiration of global health equity, making high-quality ultrasound affordable,
easy-to-use, globally accessible, and intelligently connected, including for
the 4.7 billion people around the world lacking access to ultrasound. Through
its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way
for earlier detection and remote management of health conditions around the
world. The Butterfly iQ+ can be purchased today by trained healthcare
practitioners in areas including, but not limited to, parts of Africa, Asia,
Australia, Europe, the Middle East, North America and South America; to learn
more about available countries, visit:
www.butterflynetwork.com/choose-your-country (https://pr.report/t6ojNhrz) .
Citations
1. Kainz, B., Heinrich, M.P., Makropoulos, A. et al. Non-invasive
diagnosis of deep vein thrombosis from ultrasound imaging with machine
learning. npj Digit. Med. 4, 137 (2021).
https://doi.org/10.1038/s41746-021-00503-7
Contact Information
For Butterfly Business Inquiries: Darius Shahida
Chief Strategy & Business Development Officer, Butterfly
dshahida@butterflynetinc.com (mailto:dshahida@butterflynetinc.com)
Butterfly Media: Liz Snyder
Head of Corporate Communications, Butterfly
media@butterflynetinc.com (mailto:media@butterflynetinc.com)
For ThinkSono Inquiries:
hello@thinksono.com (mailto:hello@thinksono.com)
SOURCE: ThinkSono Ltd
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAFSUFEMEDSESS